GlassScriptPhysician profile
Yi H Kao
NPI 1568488500
$3,494.32
in general payments reported to CMS, 2019-2025
12 companies · $1,035 in 2025
The $1,035 reported for 2025 was more than what 80% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $523 · 2020: $1,419 · 2021: $22.29 · 2022: $477 · 2024: $17.84 · 2025: $1,035.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $907 · Food and Beverage: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $906.60 |
| Food and Beverage | $146.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,431.14 | 2019-2020 | |
| Smith+Nephew, INC. | $1,064.00 | 2020-2025 | Tula, Coblation |
| Intersect Ent, INC. | $364.29 | 2019-2022 | |
| Optinose US, INC. | $266.33 | 2019-2022 | |
| Acclarent, INC | $174.26 | 2019-2022 | |
| Aerin Medical INC. | $73.86 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $35.16 | 2019-2022 | |
| Arrinex, INC. | $29.00 | 2019 | |
| Integra Lifesciences Corporation | $17.84 | 2024 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Greer Laboratories, INC. | $14.59 | 2019 | |
| Cochlear Americas | $12.51 | 2019 | |
| Alk-Abello, INC | $11.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yi Kao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.